Estrogen-induced lncRNA DSCAM-AS1 is reported to be highly and specifically expressed in luminal-subtype breast cancer and mediates the development of ER+ breast cancer, and tamoxifen resistance through the interacting protein, hnRNPL [20]. Here, DSCAM is linked to breast carcinoma.